Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Post-Market, Single-arm, Confirmatory Interventional Clinical Investigation to Evaluate the Performance and Safety of INNEA and INNEA AQUA for the Treatment of Cheek and décolletage Wrinkles
Authors not listed
Innate srl · 2023
Abstract
A Post-Market, Single-arm, Confirmatory Interventional Clinical Investigation to evaluate the Performance and Safety of INNEA and INNEA AQUA for the treatment of cheek and décolletage wrinkles
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Anonymous. (2023). A Post-Market, Single-arm, Confirmatory Interventional Clinical Investigation to Evaluate the Performance and Safety of INNEA and INNEA AQUA for the Treatment of Cheek and décolletage Wrinkles. <em>Innate srl</em>. https://clinicaltrials.gov/study/NCT07331181
Vancouver
Anonymous. A Post-Market, Single-arm, Confirmatory Interventional Clinical Investigation to Evaluate the Performance and Safety of INNEA and INNEA AQUA for the Treatment of Cheek and décolletage Wrinkles. Innate srl. 2023.
BibTeX
@misc{anon2023APostM,
title = {A Post-Market, Single-arm, Confirmatory Interventional Clinical Investigation to Evaluate the Performance and Safety of INNEA and INNEA AQUA for the Treatment of Cheek and décolletage Wrinkles},
author = {Anonymous},
journal = {Innate srl},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Mesoestetic Pharma Group S.L. 2022
Open access · US-GOV
An Open-label Uncontrolled Single Centre Investigation for the Evaluation of the Safety and Performance Characteristics of the Dermal Filler mGlobal L+AS, Hyaluronic Acid 20 mg/ml (M-GLO-LS) for Soft Tissue Augmentation to Correction of Light to Moderate Wrinkles and Folds
Mesoestetic Pharma Group S.L. 2022
Open access · US-GOV
An Open-label Uncontrolled Single Centre Investigation for the Evaluation of the Safety and Performance Characteristics of the Dermal Filler mIntense L+AS, Hyaluronic Acid 25 mg/ml (M-INT-LS) for Soft Tissue Augmentation to Correction of Moderate to Deep Wrinkles and Folds
Laboratoires Vivacy 2025
Open access · US-GOV
A Prospective, Multicentric, Randomized, Evaluator-blind, Controlled, Interventional Clinical Investigation Evaluating the Clinical Performance and Safety of STYLAGE® HydroMax, a Hyaluronic Acid-based Gel
Mesoestetic Pharma Group S.L. 2022
Open access · US-GOV
An Open-label Uncontrolled Single Centre Investigation for the Evaluation of the Safety and Performance Characteristics of the Dermal Filler, of Hyaluronic Acid 20 mg/ml, (M-AOX-2021) for Soft Tissue Augmentation Intended to be Used as a Temporary Dermal Filler for the Correction of Mild and Moderate Facial Wrinkles.
Central Hospital, Nancy, France 2023
Open access · US-GOV
Discard the Curative Causes of Late Onset Epilepsy: the Role of Brain 18F-FDG PET
Biopolimeri Srl 2022
Open access · US-GOV